Cleared Special

K012050 - VIATRAC 14 PLUS PERIPHERAL DILATATION C...

K012050 is the FDA 510(k) clearance for VIATRAC 14 PLUS PERIPHERAL DILATATION C... by Guidant Corp.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Special 510(k) pathway after a 66-day FDA review.

K012050 · Guidant Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2001
Decision
66d
Days
Class 2
Risk

K012050 is an FDA 510(k) clearance for the VIATRAC 14 PLUS PERIPHERAL DILATATION CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Guidant Corp. (Santa Clara, US). The FDA issued a Cleared decision on September 6, 2001 after a review of 66 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Guidant Corp. devices

Submission Details

510(k) Number K012050 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 02, 2001
Decision Date September 06, 2001
Days to Decision 66 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
59d faster than avg
Panel avg: 125d · This submission: 66d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 588
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K012050.
STENT SUPPORT GUIDE CATHETER
K010579 · Medtronic Vascular · Nov 2001
CONCENTRIC BALLOON GUIDE CATHETER, MODEL 90031
K010954 · Concentric Medical, Inc. · Oct 2001
BARD UTAVERSE SMALL VESSEL PTA BALLOON DILATATION CATHETER
K012913 · C.R. Bard, Inc. · Sep 2001
ATTAIN ACCESS 6218 LEFT-HEART DELIVERY SYSTEM, MODEL 6218
K012083 · Medtronic Vascular · Aug 2001
ATTAIN LDS 6216 LEFT-HEART DELIVERY SYSTEM
K012130 · Medtronic Vascular · Aug 2001
VIKING OPTIMA GUIDING CATHETER
K012002 · Guidant Corp. · Jul 2001